Quantcast
Channel: WN.com - Articles related to Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia (Actelion Ltd)
Viewing all articles
Browse latest Browse all 480

Actelion Using Combination Strategy to Attack Multiple Sclerosis

$
0
0
Actelion Ltd. is seeking more effective treatments for people suffering from multiple sclerosis by following a strategy that’s worked in treating HIV, cancer and heart failure -- combining medicines to increase their potency. The company has begun late-stage testing for its...

Viewing all articles
Browse latest Browse all 480

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>